When compared with placebo, vunakizumab is a safe and efficacious treatment for moderate to severe plaque psoriasis among adults.

The FDA has approved Botox® Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of platysma bands.

The risk for an incident diagnosis of type 2 diabetes is increased in the 6 months following SARS-CoV-2 infection.

PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.

During the 2023-2024 school year, fewer United States kindergarteners had complete vaccinations than in prior years.

The perception of risk related to climate change among emergency medical societies differs according to geographical position, and few have implemented assessment and preparedness measures for climate ...

Used in over a quarter of all cases included as part of a systematic review, rivaroxaban was the most common treatment used for livedoid vasculopathy.

As of 2020, there were about 2.1 million AYA cancer survivors in the United States, and about 69% were at least 10 years from diagnosis.

Telogen effluvium prevalence has significantly increased following the COVID-19 pandemic, but no association was observed for COVID-19 vaccines.

In a systematic review, the incidence of gastrointestinal-related adverse events associated with the use of biologic therapies for psoriasis was 8.7%.

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

The policy of billing for secure messages changes patient expectations and can impact the patient-physician relationship.